Danish Covid-19 treatment approved for human trials

The goal of the new inhalation therapy is to also treat other infections such as influenza.

Photo: Marcus Emil Christensen

A new treatment for Covid-19, which is being developed by Danish scientists, has now been approved for its first clinical trial in humans, Danish hospital Rigshospitalet reports in a press release.

The treatment is an inhalation therapy where a patient is administered a mild acid solution to help the immune system fight infections in the airways.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Lundbeck chairman demands change: "We can't live with this"

Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.

Eli Lilly upgrades earnings per share guidance

On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.

Further reading

Related articles

Trial banner

Latest news

See all jobs